Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01061294 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Outcomes Using the AMO Advanced Customvue™ iLasik Procedure
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01061294: Completed Phase 4 study, sponsored by Innovative Medical.
NCT01061294 is a Phase 4 study that has completed, run by Innovative Medical. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01061294, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure (WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System). Patient data will be collected electronically and analyzed to determine improvements in postoperative visual acuity, visual quality and residual error.
Interventions
- PROCEDURE Advanced CustomVue™ iLASIK procedure
- DEVICE WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
What the finished NCT01061294 record still lists
NCT01061294 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Advanced CustomVue™ iLASIK procedure is the first listed.
NCT01061294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01061294 about?
NCT01061294 is a clinical study titled "Evaluation of Outcomes Using the AMO Advanced Customvue™ iLasik Procedure". The purpose of this study is to assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure (WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System). Patient data will be collected electronically and analyzed to determine improvements in ...
What is the current status of trial NCT01061294?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2009-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01061294?
The interventions under investigation include: Advanced CustomVue™ iLASIK procedure (PROCEDURE), WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System (DEVICE).
Who is sponsoring clinical trial NCT01061294?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01061294's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia